BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
160 results:

  • 1. Regulation of the P53 tumor suppressor gene and the mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
    Akbari P; Taebpour M; Akhlaghi M; Hasan SH; Shahriyari S; Parsaeian M; Haghirosadat BF; Rahdar A; Pandey S
    Med Oncol; 2024 Jan; 41(3):68. PubMed ID: 38289404
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model.
    Tang H; Xie J; Du YX; Tan ZJ; Liang ZT
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):48. PubMed ID: 38285218
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Malignant glomus tumor arising in association with a fumarate hydratase-deficient leiomyoma: An unusual collision tumor.
    Short EL; Logan SJ; Thangaiah JJ; Folpe AL
    J Cutan Pathol; 2024 Apr; 51(4):272-275. PubMed ID: 38140939
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
    Pardanani A; Reichard K; Tefferi A
    Br J Haematol; 2024 Feb; 204(2):402-414. PubMed ID: 38054381
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Is liquid nitrogen recycled bone and vascular fibula combination the biological reconstruction of choice in lower extremity long bone tumor-related defects?
    Özger H; Alpan B; Eralp L; Valiyev N; Sungur M; Aycan OE; Salduz A
    J Surg Oncol; 2023 Oct; 128(5):902-915. PubMed ID: 37428092
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.
    Moore LN; Holmes DL; Sharma A; Landazuri Vinueza J; Lagunoff M
    PLoS Pathog; 2023 May; 19(5):e1011385. PubMed ID: 37163552
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fumarate Hydratase and S-(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2% of Uterine Leiomyosarcomas: A Cohort Study of 348 Tumors.
    Chapel DB; Sharma A; Maccio L; Bragantini E; Zannoni GF; Yuan L; Quade BJ; Parra-Herran C; Nucci MR
    Int J Gynecol Pathol; 2023 Mar; 42(2):120-135. PubMed ID: 36729957
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
    Pascual-Pasto G; Resa-Pares C; Castillo-Ecija H; Aschero R; Baulenas-Farres M; Vila-Ubach M; Burgueño V; Balaguer-Lluna L; Cuadrado-Vilanova M; Olaciregui NG; Martinez-Velasco N; Perez-Jaume S; de Alava E; Tirado OM; Lavarino C; Mora J; Carcaboso AM
    Biochem Pharmacol; 2023 Feb; 208():115408. PubMed ID: 36603685
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High-content drug screening in zebrafish xenografts reveals high efficacy of dual mcl-1/BCL-X
    Grissenberger S; Sturtzel C; Wenninger-Weinzierl A; Radic-Sarikas B; Scheuringer E; Bierbaumer L; Etienne V; Némati F; Pascoal S; Tötzl M; Tomazou EM; Metzelder M; Putz EM; Decaudin D; Delattre O; Surdez D; Kovar H; Halbritter F; Distel M
    Cancer Lett; 2023 Feb; 554():216028. PubMed ID: 36462556
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors.
    Sobol B; Azzam Nieto O; Eberlein EL; Scherr AL; Ismail L; Kessler A; Nader L; Schwab M; Hoffmeister P; Schmitt N; Jäger D; Welte S; Seidensaal K; Christopoulos P; Heilig C; Kriegsmann K; Fröhling S; Kriegsmann M; Hess J; Köhler BC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887198
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.
    Yuan Y; Li D; Hu X; Li Y; Yi W; Li P; Zhao Y; Li Z; Yu A; Jian C; Yu A
    Med Oncol; 2022 Apr; 39(5):87. PubMed ID: 35478053
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
    Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
    Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic utility of ERG immunostaining in dermatofibroma.
    Yamada Y; Ichiki T; Susuki Y; Yamada-Nozaki Y; Tateishi Y; Furue M; Oda Y
    J Clin Pathol; 2023 Aug; 76(8):536-540. PubMed ID: 35318257
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions.
    Kaur H; Kala S; Sood A; Mridha AR; Kakkar A; Yadav R; Mishra S; Mishra D
    Head Neck Pathol; 2022 Sep; 16(3):728-737. PubMed ID: 35220546
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Asiatic Acid Induces Mitochondrial Apoptosis via Inhibition of JAK2/STAT3 Signalling Pathway in Human Osteosarcoma.
    Yan BF; Chen X; Liu J; Liu SJ; Zhang JZ; Zeng QQ; Duan JA
    Folia Biol (Praha); 2021; 67(3):108-117. PubMed ID: 35151244
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.
    Wei JJ
    Semin Diagn Pathol; 2022 May; 39(3):187-200. PubMed ID: 35144823
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.
    Erdogdu U; Dolgikh N; Laszig S; Särchen V; Meister MT; Wanior M; Knapp S; Boedicker C
    Neoplasia; 2022 Feb; 24(2):109-119. PubMed ID: 34959030
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel 1,3,5-triazine-nicotinohydrazide derivatives induce cell arrest and apoptosis in osteosarcoma cancer cells and inhibit osteosarcoma in a patient-derived orthotopic xenograft mouse model.
    Su Q; Xu B; Tian Z; Gong Z
    Chem Biol Drug Des; 2022 Feb; 99(2):320-330. PubMed ID: 34811888
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A combinatorial drug screen in PDX-derived primary rhabdomyosarcoma cells identifies the NOXA - BCL-XL/mcl-1 balance as target for re-sensitization to first-line therapy in recurrent tumors.
    Manzella G; Moonamale DC; Römmele M; Bode P; Wachtel M; Schäfer BW
    Neoplasia; 2021 Sep; 23(9):929-938. PubMed ID: 34329950
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.